Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

April 2010
1. PARRA E , Ferreira J
   The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines.
   Oncol Rep. 2010;23:1159-65.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. WANG L , Wang ZY
   The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.
   Oncol Rep. 2010;23:1109-17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KIM JH , Cho YH, Park YL, Sohn JH, et al
   Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer.
   Oncol Rep. 2010;23:989-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. ZANG S , Chen F, Dai J, Guo D, et al
   RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer.
   Oncol Rep. 2010;23:893-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
5. TSUNODA Y , Suzuki K, Tsunoda A, Takimoto M, et al
   Evaluation of 5-fluorouracil related genes in breast cancer to predict the effect of adjuvant therapy with oral fluorouracil derivatives.
   Oncol Rep. 2010;23:771-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. HAN W , Kang SY, Kang D, Park SK, et al
   Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
   Oncol Rep. 2010;23:763-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. TSUTSUI S , Matsuyama A, Yamamoto M, Takeuchi H, et al
   The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer.
   Oncol Rep. 2010;23:621-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. XIANG M , Gu Y, Zhao F, Lu H, et al
   Mast cell tryptase promotes breast cancer migration and invasion.
   Oncol Rep. 2010;23:615-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
9. ESCUDERO-ESPARZA A , Martin TA, Douglas-Jones A, Mansel RE, et al
   PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.
   Oncol Rep. 2010;23:537-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. CZARNECKA AM , Klemba A, Krawczyk T, Zdrozny M, et al
    Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor.
    Oncol Rep. 2010;23:531-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. CAO S , Li Y, Li J, Li CF, et al
    Quantitative determination of HER2 expression by confocal microscopy assay in CTCs of breast cancer.
    Oncol Rep. 2010;23:423-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. STAFF S , Isola J, Jumppanen M, Tanner M, et al
    Aurora-A gene is frequently amplified in basal-like breast cancer.
    Oncol Rep. 2010;23:307-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
13. LEE J , Hwangbo C, Lee JJ, Seo J, et al
    The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Oncol Rep. 2010;23:229-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
14. CHOI EJ , Kim GH
    5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells.
    Oncol Rep. 2009;22:1533-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. HENRIQUEZ-HERNANDEZ LA , Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, et al
    Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study.
    Oncol Rep. 2009;22:1425-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
16. HRSTKA R , Beranek M, Klocova K, Nenutil R, et al
    Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer.
    Oncol Rep. 2009;22:1205-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. MATSUURA K , Yamaguchi Y, Osaki A, Ohara M, et al
    FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients.
    Oncol Rep. 2009;22:1181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. JUNG MY , Kim SH, Cho D, Kim TS, et al
    Analysis of the expression profiles of cytokines and cytokine-related genes during the progression of breast cancer growth in mice.
    Oncol Rep. 2009;22:1141-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CHANG HJ , Yang MJ, Yang YH, Hou MF, et al
    MMP13 is potentially a new tumor marker for breast cancer diagnosis.
    Oncol Rep. 2009;22:1119-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SCHRODER C , Schumacher U, Fogel M, Feuerhake F, et al
    Expression and prognostic value of L1-CAM in breast cancer.
    Oncol Rep. 2009;22:1109-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
21. QIU J , Wang X, Guo X, Zhao C, et al
    Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
    Oncol Rep. 2009;22:935-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KOIKE FOLGUEIRA MA , Brentani H, Carraro DM, De Camargo Barros Filho M, et al
    Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy.
    Oncol Rep. 2009;22:805-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
23. DU Q , Zhang Y, Tian XX, Li Y, et al
    MAGE-D1 inhibits proliferation, migration and invasion of human breast cancer cells.
    Oncol Rep. 2009;22:659-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SILVA SN , Azevedo AP, Teixeira V, Pina JE, et al
    The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: A case-control study in the Portuguese population.
    Oncol Rep. 2009;22:593-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LANG A , Palmeback Wegman P, Wingren S
    The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer.
    Oncol Rep. 2009;22:575-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. KIM JY , Lee CS, Kim HO, Jo YH, et al
    The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Oncol Rep. 2009;22:487-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
27. ARUGA T , Suzuki E, Saji S, Horiguchi S, et al
    A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer.
    Oncol Rep. 2009;22:273-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
28. GAST MC , Van Gils CH, Wessels LF, Harris N, et al
    Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Oncol Rep. 2009;22:205-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. NAKAJIMA S , Niizeki H, Tada M, Nakagawa K, et al
    Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231.
    Oncol Rep. 2009;22:143-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TOWER AM , Trinward A, Lee K, Joseph L, et al
    AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
    Oncol Rep. 2009;22:49-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
31. LEE EY , Jeon MJ, Yang W, Shin I, et al
    Effect of p27 on motility of MDA-MB-231 breast cancer cells.
    Oncol Rep. 2009;21:1621-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. NKHATA KJ , Ray A, Schuster TF, Grossmann ME, et al
    Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.
    Oncol Rep. 2009;21:1611-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. MALTA-VACAS J , Chauvin C, Goncalves L, Nazare A, et al
    eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development.
    Oncol Rep. 2009;21:1551-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. ANDROUTSOPOULOS VP , Mahale S, Arroo RR, Potter G, et al
    Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
    Oncol Rep. 2009;21:1525-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MITSUMORI M , Hiraoka M, Inaji H, Noguchi S, et al
    Impact of radiation therapy on breast-conserving therapy for breast cancer in Japanese women: A retrospective analyses of multi-institutional experience. Kansai Breast Cancer Radiation Therapy Study Group.
    Oncol Rep. 2009;21:1461-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. MELLO ML , Russo P, Russo J, Vidal BC, et al
    Entropy of Feulgen-stained 17-beta-estradiol-transformed human breast epithelial cells as assessed by restriction enzymes and image analysis.
    Oncol Rep. 2009;21:1483-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. TRINKAUS M , Ooi WS, Amir E, Popovic S, et al
    Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
    Oncol Rep. 2009;21:1153-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. KANG S , Kim ES, Moon A
    Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.
    Oncol Rep. 2009;21:1317-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
39. ZHANG Y , Yao F, Yao X, Yi C, et al
    Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Oncol Rep. 2009;21:1113-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. RECCHIA F , Sica G, Candeloro G, Necozione S, et al
    Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: Long-term follow-up of a phase II study.
    Oncol Rep. 2009;21:1011-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. ETIQUE N , Grillier-Vuissoz I, Lecomte J, Flament S, et al
    Crosstalk between adenosine receptor (A2A isoform) and ERalpha mediates ethanol action in MCF-7 breast cancer cells.
    Oncol Rep. 2009;21:977-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. PLAK K , Czarnecka AM, Krawczyk T, Golik P, et al
    Breast cancer as a mitochondrial disorder (Review).
    Oncol Rep. 2009;21:845-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
43. SHIEN T , Kinoshita T, Shimizu C, Hojo T, et al
    Primary tumor resection improves the survival of younger patients with metastatic breast cancer.
    Oncol Rep. 2009;21:827-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. WARM M , Kates R, Dick M, Thomas A, et al
    Optimized pro-active management of anemia by Epoetin alpha in pre-operative chemotherapy for primary breast cancer.
    Oncol Rep. 2009;21:777-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. RICHERT MM , Vaidya KS, Mills CN, Wong D, et al
    Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
    Oncol Rep. 2009;21:761-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. YONEYA T , Tsunenari T, Taniguchi K, Kanbe Y, et al
    Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.
    Oncol Rep. 2009;21:747-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. HUANG GL , Zhang XH, Guo GL, Huang KT, et al
    Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
    Oncol Rep. 2009;21:673-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. CHOU CC , Wu YC, Wang YF, Chou MJ, et al
    Capsaicin-induced apoptosis in human breast cancer MCF-7 cells through caspase-independent pathway.
    Oncol Rep. 2009;21:665-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
49. NEUBAUER H , Ruoff A, Paessler N, Solomayer E, et al
    A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
    Oncol Rep. 2009;21:475-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. WANG YA , Johnson SK, Brown BL, Dobson PR, et al
    Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
    Oncol Rep. 2009;21:437-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. NOGI H , Kobayashi T, Suzuki M, Tabei I, et al
    EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.
    Oncol Rep. 2009;21:413-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. LAHIRI M , Martin JH
    Nitric oxide decreases motility and increases adhesion in human breast cancer cells.
    Oncol Rep. 2009;21:275-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. HAAS S , Gevensleben H, Rabstein S, Harth V, et al
    Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers.
    Oncol Rep. 2009;21:299-304.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
54. STEBEL A , Brachetti C, Kunkel M, Schmidt M, et al
    Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1.
    Oncol Rep. 2009;21:217-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. BU Y , Lu C, Bian C, Wang J, et al
    Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin.
    Oncol Rep. 2009;21:13-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
56. REINHOLD U , Schmitz B, Kurbacher C, Nagel W, et al
    Circulating 25-hydroxyvitamin D concentration in German cancer patients.
    Oncol Rep. 2008;20:1539-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. LOPEZ-BONET E , Alonso-Ruano M, Barraza G, Vazquez-Martin A, et al
    Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    Oncol Rep. 2008;20:1369-74.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: